Cargando…
Improving T cell therapy: in vivo CRISPR-Cas9 screens tell us how to do
A commentary on “In vivo CD8(+) T cell CRISPR screening reveals control by Fli1 in infection and cancer”.
Autor principal: | Yin, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982609/ https://www.ncbi.nlm.nih.gov/pubmed/35693219 http://dx.doi.org/10.1093/pcmedi/pbab015 |
Ejemplares similares
-
CRISPR-Cas9 for in vivo Gene Therapy: Promise and Hurdles
por: Dai, Wei-Jing, et al.
Publicado: (2016) -
CRISPR/Cas9 or prime editing? – It depends on…
por: Schenke, Dirk
Publicado: (2020) -
Ethical implications of fighting malaria with CRISPR/Cas9
por: Patrão Neves, Maria, et al.
Publicado: (2017) -
Optimization of genome editing through CRISPR-Cas9 engineering
por: Zhang, Jian-Hua, et al.
Publicado: (2016) -
What do the Universal Test and Treat trials tell us about the path to HIV epidemic control?
por: Havlir, Diane, et al.
Publicado: (2020)